Arcadia Biosciences, Inc.

What they do

Arcadia sells coconut water products under the Zola brand, which it acquired in May 2021, and generates revenue primarily through Zola product sales. Historically the company developed wheat traits commercialized through food product sales, trait licensing and royalty agreements, but it sold the GoodWheat brand to Above Food on May 16, 2024 for net consideration of $3.7 million. The company is now focused on the consumer goods beverage business.

Revenue drivers

• Zola coconut water — The company's sole operating beverage line; second quarter 2026 total revenues were $1,443 thousand, with Zola revenues down $112 thousand, or 4%, in the first half of 2026 versus the prior year.
• New product launches — Management plans a 1-liter espresso launch in Q4 2026, which it says has pre-launch commitments from its two largest customers, followed by three additional new products planned for the first half of 2027.

Recent performance

Second quarter 2026 total revenues were $1,443 thousand versus $1,455 thousand in the second quarter of 2025, a decline of $12 thousand, or 1%. Loss from continuing operations was $496 thousand in the second quarter of 2026 versus $501 thousand in the prior-year period. Net loss attributable to common stockholders was $6,266 thousand in the second quarter of 2026, compared with $4,458 thousand in the second quarter of 2025. Net cash used in operating activities was $319 thousand for the quarter, and cash and equivalents were $4.2 million at June 30, 2026.

Strategy

Management is focused on funding and accelerating Zola's growth after raising $4 million in gross proceeds through a June 2026 private placement. The company is launching a 1-liter espresso product in Q4 2026 and three additional products in the first half of 2027. It has reduced selling, general and administrative expenses, which fell $1.0 million in the second quarter of 2026 versus the prior-year period and reached what management called an all-time low. The earlier plan to combine with Roosevelt Resources in an all-stock transaction was terminated by Roosevelt effective December 24, 2025.

Risks

• Narrow product line — Revenue depends on Zola coconut water, and second quarter and first-half 2026 shortfalls were driven by low inventory balances and longer-than-expected shipping times.
• Continued losses — The company reported a net loss attributable to common stockholders of $6,266 thousand in the second quarter of 2026 and sustained annual net losses from 2021 through 2025.
• Listing-rule failures — The company reported delisting notices or listing-rule failures in 8-K filings on August 10, 2026 and September 4, 2026.
• Limited cash and equity base — At June 30, 2026 the company had $4.2 million in cash and equivalents against total liabilities of $5.3 million and shareholder equity of $633 thousand.

Outlook

Management said Zola has reached an inflection point and is entering a new growth phase, noting July monthly Zola sales topped $740 thousand and exceeded $1 million through the first week of August 2026. The company expects growth to accelerate from the Q4 2026 espresso launch and three additional products planned for the first half of 2027. It states the June 2026 private placement gives it the cash to fund that growth.